Skip to main content
. Author manuscript; available in PMC: 2014 Jul 21.
Published in final edited form as: Cancer Biol Ther. 2007 Oct 19;7(1):135–144. doi: 10.4161/cbt.7.1.5199

Figure 2.

Figure 2

The distribution of ASE in human samples. The ASE score (θ) distribution for all heterozygous individuals tested, CEPH and NFPTR, is shown. The mean score for 17,237 heterozygotes is 0.65 with 3.6% (625/17,237) showing “extreme” ASE (θ ≥ 2).